IDXX IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. (IDXX) is expected to report earnings on November 3, 2026, before the market open. The consensus earnings estimate is $3.70 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -8.5% since its last earnings release on August 4, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About IDEXX Laboratories, Inc.
IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for the veterinary, bioresearch, water, livestock, poultry and dairy markets.
Sector
Healthcare
Industry
Diagnostic Substances